Natallia Varankovich

Natallia Varankovich

Auto-generated profile, based on publicly available information

Natallia Varankovich

Department of Pediatrics, University of British Columbia, and BC Children’s Hospital, 4480 Oak Street, Vancouver, BC V6H 3V4, Canada

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2015 in Frontiers in Microbiology
Verified
Journal Article
Open access
NVNatallia V. Varankovich
Natallia V. Varankovich
MNMichael T. Nickerson
Michael T. Nickerson
DKDarren Korber
Darren Korber
Probiotic bacteria offer a number of potential health benefits when administered in sufficient amounts that in part include reducing the number of harmful organisms in the intestine, producing antimicrobial substances and stimulating the body's immune response. However, precisely elucidating the probiotic effect of a specific bacterium has been challenging due to the complexity of the gut's microbial ecosystem and a lack of definitive means for its characterization. This review provides an overview of widely used and recently described probiotics, their impact on the human's gut microflora as a preventative treatment of disease, human/animal models being used to help show efficacy, and discusses the potential use of probiotics in gastrointestinal diseases associated with antibiotic administration.

6 May 2020 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
BBByron Brook
Byron Brook
DHDanny J. Harbeson
Danny J. Harbeson
CSCasey P. Shannon
Casey P. Shannon
BCBing Cai
Bing Cai
DHDaniel He
Daniel He
NANelly Amenyogbe
Nelly Amenyogbe
Neonatal administration of BCG vaccine rapidly increases neutrophil production to reduce mortality from sepsis.

1 December 2016 in Food Chemistry
Verified
Journal Article
Closed access
CCC. Chang
C. Chang
NVN. Varankovich
N. Varankovich
MNMichael Nickerson
Michael Nickerson

1 November 2016 in Food Research International
Verified
Journal Article
Closed access
JKJae He Kim
Jae He Kim
NVNatallia V. Varankovich
Natallia V. Varankovich
ASAndrea K. Stone
Andrea K. Stone
MNMichael Nickerson
Michael Nickerson

28 February 2017 in Food Science and Biotechnology
Verified
Journal Article
Closed access
PDF file
NVNatallia Varankovich
Natallia Varankovich
MMMaria F. Martinez
Maria F. Martinez
MNMichael T. Nickerson
Michael T. Nickerson
DKDarren Korber
Darren Korber

27 January 2019 in Journal of Visualized Experiments
Verified
Journal Article
Open access
PDF file
BBByron Brook
Byron Brook
NANelly Amenyogbe
Nelly Amenyogbe
RBRym Ben-Othman
Rym Ben-Othman
BCBing Cai
Bing Cai
DHDanny Harbeson
Danny Harbeson
TKTobias R. Kollmann
Tobias R. Kollmann
Neonatal sepsis remains a global burden. A preclinical model to screen effective prophylactic or therapeutic interventions is needed. Neonatal mouse polymicrobial sepsis can be induced by injecting cecal slurry intraperitoneally into day of life 7 mice and monitoring them for the following week. Presented here are the detailed steps necessary for the implementation of this neonatal sepsis model. This includes making a homogeneous cecal slurry stock, diluting it to a weight- and litter-adjusted dose, an outline of the monitoring schedule, and a definition of observed health categories used to define humane endpoints. The generation of a homogeneous cecal slurry stock from pooled donors allows for the administration into many litters over time, reducing the variation between donors, and preventing the use of potentially toxic glycerol. The monitoring strategy used allows for the anticipation of survival outcome and the identification of mice that would later progress to death, allowing for an earlier identification of the humane endpoint. Two main behavioral features are used to define the health scores, namely, the ability of the neonatal mice to right themselves when placed on their back and their level of mobility. These criteria could potentially be applied to address humane endpoints in other studies of neonatal disease in mice, as long as a pilot study is performed to confirm accuracy. In conclusion, this approach provides a standardized method to model newborn sepsis in mice, while providing resources to assess animal welfare used to define early humane endpoints for challenged animals.